Vanguard Group’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $521K | Sell |
|
|||||
|
2023
Q1 | $280K | Hold |
|
|||||
|
2022
Q4 | $105K | Hold |
|
|||||
|
2022
Q3 | $152K | Buy |
|
|||||
|
2022
Q2 | $204K | Sell |
|
|||||
|
2022
Q1 | $456K | Sell |
|
|||||
|
2021
Q4 | $1.46M | Buy |
|
|||||
|
2021
Q3 | $2.28M | Buy |
|
|||||
|
2021
Q2 | $3.84M | Sell |
|
|||||
|
2021
Q1 | $8.24M | Buy |
|
|||||
|
2020
Q4 | $1.68M | Buy |
|